Paper Details
- Home
- Paper Details
Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.
Author: DestaZ, DukeJ, ElmendorfJ S, FlockhartD A, HanX, LiL, QuinneyS K, WangZ, ZhangP
Original Abstract of the Article :
Myopathy is a group of muscle diseases that can be induced or exacerbated by drug-drug interactions (DDIs). We sought to identify clinically important myopathic DDIs and elucidate their underlying mechanisms. Five DDIs were found to increase the risk of myopathy based on analysis of observational da...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/25975815
データ提供:米国国立医学図書館(NLM)
Drug-Drug Interactions and Myopathy: Navigating the Desert of Potential Risks
Pharmacology, like a vast desert, is filled with intricate interactions and potential risks. This study investigates the complex world of drug-drug interactions (DDIs) and their potential to induce or exacerbate myopathy, a group of muscle diseases. The researchers used a translational approach, combining observational data and in vitro studies, to identify clinically important DDIs and explore their underlying mechanisms. Their findings reveal the importance of carefully considering potential DDIs to minimize the risk of myopathy.
Loratadine: A Potential Culprit in Myopathy
The study identifies loratadine as a key player in several DDIs associated with an increased risk of myopathy. The researchers found that loratadine, when combined with simvastatin, alprazolam, ropinirole, and omeprazole, significantly increased the risk of myopathy. This finding highlights the importance of careful drug selection and monitoring to avoid these potentially harmful combinations.
Minimizing Myopathy Risk: A Collaborative Effort
The study emphasizes the importance of collaboration between clinicians, pharmacists, and researchers to minimize the risk of myopathy. This collaborative effort, like a caravan navigating a challenging desert, requires vigilance, communication, and a shared commitment to patient safety. By understanding the potential risks of DDIs, we can work together to ensure safe and effective drug therapy for all patients.
Dr. Camel's Conclusion
This study is like a compass in the desert of DDI research, helping us navigate potential risks and promote patient safety. By understanding the complex interactions between drugs, we can work together to ensure that medications are used safely and effectively. It is a reminder that knowledge is power, and that by working together, we can overcome the challenges of pharmacology and create a healthier world.
Date :
- Date Completed 2015-11-03
- Date Revised 2021-12-03
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.